Federal Register / Vol. 72, No. 58 / Tuesday, March 27, 2007 / Notices 14297 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to § 1301.33(a) of Title 21 of 

the Code of Federal Regulations (CFR), 

this is notice that on January 5, 2007, 

Roche Diagnostics Operations, Inc., 

Attn: Regulatory Compliance, 9115 

Hague Road, Indianapolis, Indiana 

46250, made application by renewal to 

the Drug Enforcement Administration 

(DEA) to be registered as a bulk 

manufacturer of the basic classes of 

controlled substances listed in schedule 

I and II: 

Drug Schedule 

Lysergic Acid Diethylamide (7315) I 

Tetrahydrocannabinols (7370) ..... I 

Alphamethadol (9605) .................. I 

Phencyclidine (7471) .................... II 

Ecgonine (9180) ........................... II 

Methadone (9250) ........................ II 

Morphine (9300) ........................... II 

The company plans to manufacture 

small quantities of the listed controlled 

substances for use in diagnostic 

products. 

Any other such applicant and any 

person who is presently registered with 

DEA to manufacture such a substance 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such written comments or 

objections being sent via regular mail 

should be addressed, in quintuplicate, 

to the Deputy Assistant Administrator, 

Office of Diversion Control, Drug 

Enforcement Administration, Attention: 

DEA Federal Register Representative/ 

ODL, Washington, DC 20537; or any 

being sent via express mail should be 

sent to DEA Headquarters, Attention: 

DEA Federal Register Representative/ 

ODL, 2401 Jefferson-Davis Highway, 

Alexandria, Virginia 22301; and must be 

filed no later than May 29, 2007. 

Dated: March 19, 2007. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E7–5510 Filed 3–26–07; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to § 1301.33(a) of Title 21 of 

the Code of Federal Regulations (CFR), 

this is notice that on January 26, 2007, 

Stepan Company, Natural Products 

Dept., 100 W. Hunter Avenue, 

Maywood, New Jersey 07607, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

the basic classes of controlled 

substances listed in schedule II: 

Drug Schedule 

Cocaine (9041) ............................. II 

Ecgonine (9180) ........................... II 

The company plans to manufacture 

the listed controlled substances in bulk 

for distribution to its customers. 

Any other such applicant and any 

person who is presently registered with 

DEA to manufacture such a substance 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such written comments or 

objections being sent via regular mail 

should be addressed, in quintuplicate, 

to the Deputy Assistant Administrator, 

Office of Diversion Control, Drug 

Enforcement Administration, Attention: 

DEA Federal Register Representative/ 

ODL, Washington, DC 20537; or any 

being sent via express mail should be 

sent to DEA Headquarters, Attention: 

DEA Federal Register Representative/ 

ODL, 2401 Jefferson-Davis Highway, 

Alexandria, Virginia 22301; and must be 

filed no later than May 29, 2007. 

Dated: March 19, 2007. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E7–5509 Filed 3–26–07; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Application 

Pursuant to 21 U.S.C. § 958(i), the 

Attorney General shall, prior to issuing 

a registration under this Section to a 

bulk manufacturer of a controlled 

substance in schedule I or II and prior 

to issuing a regulation under 21 U.S.C. 

952(a) authorizing the importation of 

such a substance, provide 

manufacturers holding registrations for 

the bulk manufacture of the substance 

an opportunity for a hearing. 

Therefore, in accordance with 21 CFR 

1301.34(a), this is notice that on 

November 9, 2006, Tocris Cookson, Inc., 

16144 Westwoods Business Park, 

Ellisville, Missouri 63021–4500, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as an importer of the basic 

classes of controlled substances listed in 

schedule I: 

Drug Schedule 

Marihuana (7360) ......................... I 

Tetrahydrocannabinols (7370) ..... I 

The company plans to import the 

above listed synthetic products for nonclinical laboratory based research only. 

Any bulk manufacturer who is 

presently, or is applying to be, 

registered with DEA to manufacture 

such basic classes of controlled 

substances may file comments or 

objections to the issuance of the 

proposed registration and may, at the 

same time, file a written request for a 

hearing on such application pursuant to 

21 CFR 1301.43 and in such form as 

prescribed by 21 CFR 1316.47. 

Any such written comments or 

objections being sent via regular mail 

should be addressed, in quintuplicate, 

to the Deputy Assistant Administrator, 

Office of Diversion Control, Drug 

Enforcement Administration, Attention: 

DEA Federal Register Representative/ 

ODL, Washington, DC 20537; or any 

being sent via express mail should be 

sent to DEA Headquarters, Attention: 

DEA Federal Register Representative/ 

ODL, 2401 Jefferson-Davis Highway, 

Alexandria, Virginia 22301; and must be 

filed no later than April 26, 2007. 

This procedure is to be conducted 

simultaneously with and independent 

of the procedures described in 21 CFR 

1301.34(b), (c), (d), (e) and (f). As noted 

in a previous notice published in the 

Federal Register on September 23, 1975, 

(40 FR 43745–46), all applicants for 

registration to import a basic class of 

any controlled substance listed in 

schedule I or II are, and will continue 

to be required to demonstrate to the 

Deputy Assistant Administrator, Office 

of Diversion Control, Drug Enforcement 

Administration, that the requirements 

for such registration pursuant to 21 

U.S.C. 958(a), 21 U.S.C. 823(a), and 21 

CFR 1301.34(b), (c), (d), (e) and (f) are 

satisfied. 


sroberts on PROD1PC70 with NOTICES
14298 Federal Register / Vol. 72, No. 58 / Tuesday, March 27, 2007 / Notices 

Dated: March 19, 2007. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E7–5507 Filed 3–26–07; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Office of Justice Programs 

[OJP (OJJDP) Docket No. 1468] 

Meeting of the Federal Advisory 

Committee on Juvenile Justice 

AGENCY: Office of Juvenile Justice and 

Delinquency Prevention, Office of 

Justice Programs, Justice. 

ACTION: Notice of meeting. 

SUMMARY: The Office of Juvenile Justice 

and Delinquency Prevention (OJJDP) is 

announcing the spring meeting of the 

Federal Advisory Committee on 

Juvenile Justice (FACJJ), which will be 

held in Washington, DC on April 23–24, 

2007. The meeting times and location 

are noted below. 

DATES: The schedule of events is as 

follows: 

1. Sunday, April 22, 2007, 4 p.m. to 

6 p.m. 

2. Monday, April 23, 2007, 8:30 a.m. 

to 5 p.m. 

3. Tuesday, April 24, 2007, 8:30 a.m. 

to 12:30 p.m. 

ADDRESSES: All open meeting sessions 

will take place at the Office of Justice 

Programs, 810 Seventh Street, NW., 

main conference room, Washington, DC 

20531. 

FOR FURTHER INFORMATION CONTACT: 

Robin Delany-Shabazz, Designated 

Federal Official, OJJDP, Robin.DelanyShabazz@usdoj.gov, or 202–307–9963. 

[Note: This is not a toll-free number.] 

SUPPLEMENTARY INFORMATION: The 

Federal Advisory Committee on 

Juvenile Justice (FACJJ), established 

pursuant to Section 3(2)A of the Federal 

Advisory Committee Act (5 U.S.C. 

App.2) will meet to carry out its 

advisory functions under Section 

223(f)(2)(C–E) of the Juvenile Justice and 

Delinquency Prevention Act of 2002. 

The FACJJ is composed of one 

representative from each state and 

territory. FACJJ duties include: 

Reviewing Federal policies regarding 

juvenile justice and delinquency 

prevention; advising the OJJDP 

Administrator with respect to particular 

functions and aspects of OJJDP; and 

advising the President and Congress 

with regard to State perspectives on the 

operation of OJJDP and Federal 

legislation pertaining to juvenile justice 

and delinquency prevention. More 

information, including a member list, 

may be found at http://www.facjj.org. 

Meeting Agenda 

1. Sunday, April 22, 2007 

• 4 p.m.–6 p.m. New Member 

Orientation. (Closed Session). 

2. Monday, April 23, 2007 

• 8:30 a.m.–9:15 a.m. Call to Order by 

the Chair of the FACJJ and Remarks by 

the Administrator of OJJDP (Open 

Session). 

• 9:15 a.m.–12 p.m. and 1:30 p.m.–5 

p.m. Review, Discussion and 

Deliberation of the 2007 Draft Reports to 

the President, Congress, and the 

Administrator of OJJDP (Open Session). 

• 12 p.m.–1:30 p.m. Subcommittee 

Meetings (Closed Sessions). 

3. Tuesday, April 23, 2007 

• 8:30 a.m.–12:30 p.m. Continuation 

of Review, Discussion and Deliberation 

of the 2007 Draft Reports; Presentations 

and Discussions concerning Effective 

Legal Counsel; and Other Business 

(Open Session). 

For security purposes, members of the 

public who wish to attend open sessions 

of the meeting should register by 

sending an e-mail with their name, 

affiliation, address, phone number, and 

a list of sessions they plan to attend to 

ddunston@edjassociates.com. If e-mail 

is not available, fax this information to 

240–221–4006, attention: Daryel 

Dunston. Because space is limited, 

notification of intent to attend should be 

sent by April 16, 2007. 

Note: Photo identification will be required 

for admission to the meeting. Additional 

identification documents may be required. 

Space is limited. 

Written Comments 

Interested parties may submit written 

comments by Monday, April 16, 2007, 

to Robin Delany-Shabazz, Designated 

Federal Official for the Federal Advisory 

Committee on Juvenile Justice, OJJDP, at 

Robin.Delany-Shabazz@usdoj.gov. If email is not available, fax your comments 

to 202–354–4063 and call Francesca 

Stern at 202–616–3551 to ensure fax 

was received. [Note: These are not tollfree numbers.] No oral presentations 

will be permitted at the meeting. 

However, written questions and 

comments from members of the public 

attending the meeting may be invited. 

J. Robert Flores, 

Administrator, Office of Juvenile Justice and 

Delinquency Prevention. 

[FR Doc. E7–5544 Filed 3–26–07; 8:45 am] 

BILLING CODE 4410–18–P 

DEPARTMENT OF LABOR 

Office of the Secretary 

Submission for OMB Review: 

Comment Request 

March 21, 2007. 

The Department of Labor (DOL) has 

submitted the following public 

information collection request (ICR) to 

the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995 (Pub. L. 104–13, 

44 U.S.C. Chapter 35). A copy of this 

ICR, with applicable supporting 

documentation, may be obtained by 

calling Ira Mills on 202–693–4122 (this 

is not a toll-free number) or E-Mail: 

Mills.Ira@dol.gov, or by accessing 

http://www.reginfo.gov/public/do/ 

PRAMain. 

Comments should be sent to Office of 

Information and Regulatory Affairs, 

Attn: OMB Desk Officer for U.S. 

Department of Labor/Bureau of Labor 

Statistic (BLS), Office of Management 

and Budget, Room 10235, Washington, 

DC 20503, 202–395–7316 (this is not a 

toll free number), within 30 days from 

the date of this publication in the 

Federal Register. 

The OMB is particularly interested in 

comments which: 

• Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

• Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

• Enhance the quality, utility and 

clarity of the information to be 

collected; and 

• Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses. 

Agency: Bureau of Labor Statistics. 

Type of Review: Revision of a 

currently approved Collection. 

Title: National Longitudinal Survey of 

Youth. 

OMB Number: 1220–0109. 

Frequency: Biennially. 

Affected Public: Individuals or 

households. 

Type of Response: Reporting. 


sroberts on PROD1PC70 with NOTICES